| Literature DB >> 29746547 |
Alma Ryskaliyeva1, Céline Henry2, Guy Miranda1, Bernard Faye3, Gaukhar Konuspayeva4, Patrice Martin1.
Abstract
Nutritional suitability of milk is not only related to gross composition, but is also strongly affected by the microheterogeniety of the protein fraction. Hence, to go further into the evaluation of the potential suitability of non-bovine milks in human/infant nutrition it is necessary to have a detailed characterization of their protein components. Combining proven proteomic approaches (SDS-PAGE, LC-MS/MS and LC-ESI-MS) and cDNA sequencing, we provide here in depth characterization of the milk protein fraction of dromedary and Bactrian camels, and their hybrids, from different regions of Kazakhstan. A total 391 functional groups of proteins were identified from 8 camel milk samples. A detailed characterization of 50 protein molecules, relating to genetic variants and isoforms arising from post-translational modifications and alternative splicing events, belonging to nine protein families (κ-, αs1-, αs2-, β-; and γ-CN, WAP, α-LAC, PGRP, CSA/LPO) was achieved by LC-ESI-MS. The presence of two unknown proteins UP1 (22,939 Da) and UP2 (23,046 Da) was also reported as well as the existence of a β-CN short isoform (946 Da lighter than the full-length β-CN), arising very likely in both genetic variants (A and B) from proteolysis by plasmin. In addition, we report, for the first time to our knowledge, the occurrence of a αs2-CN phosphorylation isoform with 12P groups within two recognition motifs, suggesting thereby the existence of two kinase systems involved in the phosphorylation of caseins in the mammary gland. Finally, we demonstrate that genetic variants, which hitherto seemed to be species- specific (e.g. β-CN A for Bactrian and β-CN B for dromedary), are in fact present both in Camel dromedarius and C. bactrianus.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29746547 PMCID: PMC5944991 DOI: 10.1371/journal.pone.0197026
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Camel milk samples collected (n = 179) in the 3 species of the 4 regions of Kazakhstan.
| ID | Region | Coding | Bactrian | Dromedary | Hybrid | Total number of camels |
|---|---|---|---|---|---|---|
| 1 | Almaty | AL B/D/H | 13 | 20 | 1 | 34 |
| 2 | Shymkent | SH B/D/H | 20 | 21 | 20 | 61 |
| 3 | Kyzylorda | KZ B/D/H | 18 | 16 | 20 | 54 |
| 4 | Atyrau | ZKO B/D/H | 21 | 8 | 1 | 30 |
Fig 1Geographical location of camel milk sampling.
Reprinted from http://camelides.cirad.fr/fr/science/pdf/presentation_these_konuspayeva.pdf under a CC BY license, with permission from Konuspayeva Gaukhar, original copyright 2007. https://www.cia.gov/library/publications/the-world-factbook/geos/kz.html https://upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Kazakhstan_on_the_globe_%28Eurasia_centered%29.svg/512px-Kazakhstan_on_the_globe_%28Eurasia_centered%29.svg.png.
Fig 2Diagram of the experimental scheme designed for quantification and identification of camel milk proteins.
Fig 31D SDS-PAGE pattern of C. bactrianus (KZB), C. dromedarius (KZD) and hybrid (KZH) skimmed milk samples of Kyzylorda (KZ) region.
Red frames and black boxes aligned correspond to electrophoretic bands that were excised from the gel and subsequently analyzed for protein identification, after tryptic digestion, by LC-MS/MS. Molecular weight markers from 210 to 8 kDa are indicated at the right of the gel.
Top 70 proteins identified by LC-MS/MS from individual C. bactrianus (B), C. dromedarius (D) and hybrid (H) milk samples of Shymkent region.
| ID | Accession | Description | Mr | (-) log | Coverage, % | Number of Spectra | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| kDa | B | D | H | B | D | H | B | D | H | |||
| 1 | O97943-2 | Short isoform of Alpha-S1-casein | 25,7 | 453,63 | 535,3 | 585,79 | 88 | 92 | 92 | 574 | 679 | 842 |
| 2 | A0A077SL35 | Beta-casein | 26,1 | 299,05 | 285,89 | 395,72 | 77 | 79 | 79 | 542 | 507 | 745 |
| 3 | O97944 | Alpha-S2-casein | 22,9 | 285,16 | 320,65 | 276,39 | 70 | 70 | 66 | 357 | 451 | 376 |
| 4 | W6GH05 | Lactoferrin | 77,1 | 723,25 | 557,5 | 1174,16 | 85 | 80 | 88 | 253 | 157 | 829 |
| 5 | P15522-2 | Isoform B of Glycosylation-dependent cell adhesion molecule 1 | 15,4 | 112,39 | 189,45 | 192,31 | 64 | 70 | 69 | 220 | 359 | 358 |
| 6 | L0P304 | Kappa-casein | 20,3 | 127,64 | 149,66 | 194,03 | 51 | 53 | 51 | 217 | 222 | 329 |
| 7 | S9WF76 | Lactadherin-like protein | 45,6 | 263,03 | 350,07 | 501,73 | 51 | 53 | 57 | 162 | 236 | 436 |
| 8 | P00710 | Alpha-lactalbumin | 14,3 | 288,2 | 277,9 | 329,27 | 83 | 80 | 83 | 161 | 159 | 175 |
| 9 | Q9GK12 | Peptidoglycan recognition protein 1 | 21,3 | 308,94 | 359,49 | 336,8 | 73 | 73 | 79 | 112 | 156 | 140 |
| 10 | S9Z0L8 | Amine oxidase [flavin-containing] | 55,3 | 233,97 | 231,94 | 277,32 | 74 | 70 | 75 | 110 | 138 | 190 |
| 11 | S9Y4T1 | Xanthine dehydrogenase/oxidase | 150 | 270,07 | 435,86 | 330,26 | 40 | 45 | 41 | 79 | 138 | 121 |
| 12 | S9X3X3 | Butyrophilin subfamily 1 member A1 | 51,09 | 95,37 | 140,19 | 162,3 | 47 | 50 | 51 | 61 | 107 | 111 |
| 13 | S9X4G0 | Neutrophil gelatinase-associated lipocalin-like protein | 28,3 | 104,88 | 98,15 | 165,14 | 48 | 45 | 62 | 44 | 33 | 82 |
| 14 | S9X1L5 | Lipoprotein lipase isoform 3 (Fragment) | 46,5 | 107,66 | 133,72 | 54,73 | 43 | 55 | 27 | 43 | 56 | 29 |
| 15 | S9YK74 | Perilipin | 47,2 | 116,47 | 169,78 | 167,59 | 56 | 60 | 52 | 39 | 67 | 46 |
| 16 | P09837 | Whey acidic protein | 12,5 | 42,97 | 59,92 | 82,11 | 55 | 75 | 84 | 36 | 43 | 73 |
| 17 | S9X4X6 | Uncharacterized protein | 43,1 | 47,87 | 14 | 17,5 | 30 | 13 | 16 | 36 | 9 | 16 |
| 18 | S9X7Q1 | Lactoperoxidase isoform 1 preproprotein | 87,7 | 83,1 | 62,59 | 65,16 | 26 | 22 | 20 | 25 | 19 | 17 |
| 19 | S9XDK9 | Complement C3-like protein | 262,7 | 87,48 | 44,5 | 292,06 | 12 | 4 | 24 | 25 | 8 | 69 |
| 20 | S9XR87 | Beta-2-microglobulin | 14,8 | 36,87 | 36,15 | 40,76 | 43 | 43 | 43 | 23 | 28 | 44 |
| 21 | O18831 | Growth/differentiation factor 8 | 42,7 | 44,62 | 49,29 | 67,44 | 28 | 24 | 32 | 23 | 22 | 17 |
| 22 | P68103 | Elongation factor 1-alpha 1 | 50 | 58,23 | 42,59 | 78,3 | 31 | 27 | 31 | 20 | 12 | 24 |
| 23 | S9YCI6 | Peptidyl-prolyl cis-trans isomerase | 23,8 | 44,54 | 43,1 | 71,24 | 54 | 54 | 57 | 20 | 21 | 22 |
| 24 | S9XP75 | Monocyte differentiation antigen CD14 | 29,7 | 49,75 | 44,58 | 73,91 | 27 | 27 | 27 | 17 | 16 | 22 |
| 25 | S9WCV2 | Sulfhydryl oxidase | 72,2 | 31,64 | 76,49 | 14,43 | 18 | 27 | 8 | 16 | 26 | 6 |
| 26 | S9YC53 | Alpha-1-antitrypsin-like protein | 51,9 | 64,76 | 64,84 | 51,84 | 28 | 31 | 32 | 14 | 21 | 15 |
| 27 | S9YS49 | Putative E3 ubiquitin-protein ligase Roquin | 158,5 | 56,65 | 90,28 | 8,84 | 10 | 14 | 2 | 14 | 29 | 3 |
| 28 | T0NN97 | Uncharacterized protein | 151,4 | 38,86 | 53,95 | 36,72 | 12 | 13 | 11 | 13 | 16 | 15 |
| 29 | A0A0F6YEF6 | Anti-HCV NS3/4A serine protease immoglobulin heavy chain (Fragment) | 13,4 | 38,24 | 35 | 52,95 | 24 | 24 | 24 | 12 | 10 | 26 |
| 30 | S9X9X0 | Vitelline membrane outer layer protein 1-like protein | 24,2 | 44,94 | 52,11 | 75,95 | 51 | 50 | 53 | 12 | 14 | 31 |
| 31 | S9X358 | Tissue alpha-L-fucosidase | 42,7 | 25,83 | 23,27 | 24,46 | 23 | 18 | 18 | 12 | 12 | 7 |
| 32 | S9WS72 | Sodium-dependent phosphate transport protein 2B-like protein | 75,4 | 24,99 | 15,41 | 24,7 | 18 | 7 | 9 | 11 | 8 | 8 |
| 33 | S9X2V0 | UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase 1, membrane-bound form-like protein | 37,3 | 30,18 | 13,09 | 38,99 | 23 | 11 | 33 | 11 | 7 | 15 |
| 34 | S9XSQ6 | Vitamin D-binding protein-like protein | 49,3 | 41,66 | 109,25 | 18,01 | 24 | 45 | 8 | 10 | 30 | 3 |
| 35 | S9WGZ9 | Rab GDP dissociation inhibitor beta isoform 1 | 35,7 | 27,75 | 22,32 | 55,78 | 32 | 25 | 43 | 10 | 8 | 15 |
| 36 | P19120 | Heat shock cognate 71 kDa protein | 71,1 | 37,14 | 60,92 | 111,21 | 17 | 24 | 35 | 9 | 16 | 30 |
| 37 | S9XA25 | Ezrin isoform 5-like protein (Fragment) | 71 | 24,32 | 28,23 | 47,46 | 13 | 10 | 20 | 9 | 7 | 13 |
| 38 | S9XI30 | Uncharacterized protein | 22 | 25,16 | 66,23 | 20,66 | 38 | 54 | 39 | 9 | 31 | 8 |
| 39 | S9Y2X0 | Platelet glycoprotein 4 | 38,3 | 28,14 | 40,27 | 55,15 | 15 | 17 | 29 | 9 | 8 | 17 |
| 40 | G9F6X8 | Protein disulfide-isomerase | 56,3 | 20,09 | 20,62 | 21,76 | 17 | 15 | 9 | 9 | 10 | 3 |
| 41 | S9WZP7 | Serpin A3-8 | 74,9 | 15,26 | 28,06 | 72,32 | 11 | 12 | 20 | 8 | 12 | 28 |
| 42 | A7MBJ4 | Receptor-type tyrosine-protein phosphatase F | 211,1 | 23,69 | 21,19 | 20,54 | 6 | 6 | 4 | 8 | 8 | 8 |
| 43 | S9YFG2 | Complement factor D | 38,1 | 37,99 | 33,7 | 44,44 | 14 | 14 | 14 | 8 | 9 | 13 |
| 44 | S9WPL9 | Uncharacterized protein | 84,6 | 31,09 | 39,23 | 57,64 | 12 | 10 | 17 | 7 | 6 | 18 |
| 45 | S9XE02 | Beta-2-glycoprotein 1-like protein | 30,9 | 46,22 | 64,63 | 48,09 | 42 | 43 | 27 | 7 | 12 | 5 |
| 46 | B8XH67 | Na(+)/H(+) exchange regulatory cofactor NHE-RF | 39,2 | 20,94 | 37,33 | 32,94 | 22 | 22 | 30 | 7 | 9 | 11 |
| 47 | Q28452 | Quinone oxidoreductase | 35,1 | 23,01 | 24,97 | 51,04 | 28 | 25 | 43 | 7 | 5 | 11 |
| 48 | S9YU13 | Glutathione S-transferase-like protein | 27,7 | 34,68 | 8,59 | 22 | 21 | 15 | 19 | 7 | 3 | 4 |
| 49 | P00727-2 | Isoform 2 of Cytosol aminopeptidase | 53,9 | 14,58 | 13,07 | 35,48 | 15 | 9 | 18 | 6 | 4 | 7 |
| 50 | S9WUC8 | Ig kappa chain V-II region RPMI 6410-like protein | 26,7 | 22,72 | 12,39 | 32,25 | 19 | 10 | 27 | 6 | 4 | 15 |
| 51 | S9WRY0 | L-lactate dehydrogenase B chain isoform 1-like protein | 30,2 | 25,51 | 28,95 | 37,66 | 22 | 22 | 22 | 6 | 7 | 6 |
| 52 | S9X5V9 | Fc of IgG binding protein (Fragment) | 254,9 | 20,45 | 65,48 | 10,4 | 3 | 9 | 2 | 6 | 16 | 4 |
| 53 | B5B0D4 | Major allergen beta-lactoglobulin | 19,8 | 9,94 | 54,67 | 12,3 | 21 | 59 | 25 | 6 | 27 | 7 |
| 54 | S9XE13 | Uncharacterized protein | 82,6 | 12,16 | 32,28 | 71,26 | 5 | 10 | 15 | 5 | 17 | 22 |
| 55 | S9Y8C6 | Phosphoglucomutase 1 isoform 3-like protein | 68,3 | 11,37 | 18,27 | 42,46 | 9 | 11 | 22 | 5 | 6 | 11 |
| 56 | S9Y3S5 | Olfactory receptor | 108,3 | 19,83 | 37,9 | 43,59 | 4 | 6 | 7 | 5 | 9 | 11 |
| 57 | S9XT33 | Lipopolysaccharide-binding protein | 47,5 | 11,05 | 9,43 | 16,89 | 12 | 10 | 17 | 5 | 4 | 7 |
| 58 | S9YL21 | Apolipoprotein A-I | 22,5 | 19,05 | 68,11 | 82,98 | 27 | 49 | 57 | 5 | 12 | 14 |
| 59 | S9Y5X2 | Cell death activator CIDE-A-like protein | 41,2 | 16,09 | 22,41 | 15,11 | 11 | 14 | 10 | 4 | 11 | 4 |
| 60 | S9XC74 | Osteopontin isoform OPN-c | 34,6 | 8,45 | 12,77 | 34,67 | 8 | 11 | 23 | 4 | 10 | 24 |
| 61 | T0NLV9 | Epoxide hydrolase 1 | 54,3 | 7,1 | 11,53 | 12,54 | 9 | 14 | 10 | 4 | 6 | 4 |
| 62 | S9WKD1 | Ribonuclease 4 | 26,8 | 11,56 | 25,5 | 29,63 | 12 | 22 | 23 | 3 | 7 | 9 |
| 63 | S9WDV3 | Fibrinogen gamma chain isoform gamma-B | 50,5 | 7,22 | 33,1 | 76,88 | 6 | 49 | 37 | 3 | 12 | 33 |
| 64 | S9XLJ3 | Brain-specific serine protease 4-like protein | 44,6 | 7,52 | 8,26 | 9,3 | 10 | 10 | 12 | 3 | 3 | 4 |
| 65 | S9WY98 | Sodium/glucose cotransporter 1 | 78,3 | 9,01 | 5,72 | 14,27 | 4 | 3 | 5 | 3 | 2 | 5 |
| 66 | S9WX48 | Alpha-1-acid glycoprotein | 22,9 | 6,65 | 7,25 | 29,92 | 14 | 8 | 44 | 3 | 2 | 17 |
| 67 | W5P9V5 | Uncharacterized protein | 85,3 | 7,14 | 7,74 | 8,54 | 3 | 3 | 3 | 3 | 3 | 3 |
| 68 | T0NLF0 | Vitronectin | 56,2 | 11,18 | 7,8 | 25,19 | 7 | 4 | 10 | 3 | 2 | 4 |
| 69 | Q0IIG8 | Ras-related protein Rab-18 | 22,9 | 3,49 | 15,33 | 21,19 | 10 | 28 | 24 | 2 | 5 | 4 |
| 70 | S9YNY9 | Nucleobindin-1 | 53 | 4,54 | 48,27 | 20,28 | 5 | 41 | 21 | 2 | 16 | 9 |
Molecular masses (Mr) of proteins are expressed in kDa, E-value in log, coverage in %. Spectra indicates the number of spectra permitting the identification of proteins. Major proteins identified in excised gel bands after SDS-PAGE are given in bold type.
*abundance of each protein was estimated from spectral count. The number of spectra of C. bactrianus (B) classified the table.
Fig 4LC-ESI-MS profile of clarified crossed camel milk of Kyzylorda region.
Nine major milk protein fractions were identified in the following order: peak I and II contained glycosylated ant natural isoforms of κ-CN; peak III: WAP; peaks IV, V: αs1-CN; peak VI: α-LAC, αs1-CN and UP1; peak VII: αs2-CN and UP1; peaks VIII, IX, and X αs2-CN along with UP2 in peak X; peak XI: PGRP and UP2; peak XII: CSA/LPO; peaks XIII and XIV: β-CN, and peak XV: γ2-CN.
Identification of camel milk protein (hybrid from Kyzylorda region) from observed molecular masses using LC-ESI-MS.
| Peak | Ret.Time, | Observed | TheoreticalM | Protein description | UniProt/ | Intensity |
|---|---|---|---|---|---|---|
| I | 4.50 | 21,157 | 21,158 | κ-CN A, 1P, (GaN-Ga-SA2)x3 | 1,361 | |
| II | 18.61 | 18,210 | 18,210 | κ-CN B, 0P ? | L0P304 | 161 |
| 18,236 | 18,235 | κ-CN A, 0P, pyro-E | P79139 | 72 | ||
| III | 24.32 | 12,564 | 12,564 | WAP, 0P | P09837 | 1,756 |
| 12,644 | 12,644 | WAP, 1P | 1,575 | |||
| IV | 24.97 | 23,878 | 23,878 | αs1-CN A—short isoform (Δex 16 and Δex 13’), 4P | 242 | |
| V | 26.23 | 24,547 | 24,547 | αs1-CN C -short isoform (Δex 16), 5P, splice variant (ΔQ83) | 4,885 | |
| 24,707 | 24,707 | αs1-CN C—short isoform (Δex 16), 7P, splice variant (ΔQ83) | 6,990 | |||
| 24,675 | 24,675 | αs1-CN C—short isoform (Δex 16), 5P | 9,441 | |||
| 24,835 | 24,835 | αs1-CN C—short isoform (Δex 16), 7P | 7,046 | |||
| 24,689 | 24,689 | αs1-CN A—short isoform (Δex 16), 5P | 9,748 | |||
| 24,849 | 24,849 | αs1-CN A—short isoform (Δex 16), 7P | 6,909 | |||
| VI | 28.53 | |||||
| 22,939 | n/a | Uncharacterized protein 1 (UP1) | n/a | 2,701 | ||
| 23,020 | n/a | UP1+80Da | n/a | 2,489 | ||
| 23,099 | n/a | UP1+160Da | n/a | 1,079 | ||
| 25,646 | 25,645 | αs1-CN C, 6P, splice variant (ΔQ83) | 3,501 | |||
| 25,693 | 25,693 | αS1-CN C, 5P | 564 | |||
| VII | 30.05 | 21,825 | 21,826 | αs2-CN, 7P | 552 | |
| 21,984 | 21,986 | αs2-CN, 9P | 403 | |||
| 23,178 | n/a | UP1+240Da | n/a | 1,256 | ||
| VIII | 31.11 | 21,986 | 21,986 | αs2-CN, 9P | O97944 | 356 |
| IX | 33.18 | 22,066 | 22,066 | αs2-CN, 10P | 148 | |
| X | 35.05 | 22,226 | 22,226 | αs2-CN, 12P | 894 | |
| 23,046 | n/a | Uncharacterized protein 2 (UP2) | n/a | 231 | ||
| X | 37.16 | |||||
| 23,206 | n/a | UP2+160Da | n/a | 1,592 | ||
| 23,286 | n/a | UP2+240Da | n/a | 735 | ||
| XII | 38.09 | 66,481 | 66,477 | CSA ? | XP_010981066.1 | 1,096 |
| 66,491 | LPO ? | Q9GJW6 | ||||
| 66,512 | n/a | CSA ? LPO? | 2,663 | |||
| 67,342 | n/a | CSA ? LPO? | 1,010 | |||
| XIII | 40.67 | 24,746 | 24,745 | β-CN A, 3P, splice variant (ΔQ29) | 2,073 | |
| 24,793 | 24,792 | β-CN A, 2P | 5,469 | |||
| 24,825 | 24,825 | β-CN A, 4P, splice variant (ΔQ29) | 9,586 | |||
| 24,873 | 24,872 | β-CN A, 3P | 10,177 | |||
| 24,842 | 24,842 | β-CN B, 4P, splice variant (ΔQ29) | 10,029 | |||
| 24,891 | 24,890 | β-CN B, 3P | 10,365 | |||
| XIV | 43.71 | 23,878 | 23,878 | β-CN A-short isoform (Δ946 Da), 4P, splice variant (ΔQ29) | 707 | |
| 23,963 | 23,958 | β-CN A-short isoform (Δ946 Da), 5P, splice variant (ΔQ29) | 244 | |||
| 23,929 | 23,926 | β-CN A-short isoform (Δ946 Da), 3P | 438 | |||
| 23,895 | 23,896 | β-CN B-short isoform (Δ946 Da), 4P, splice variant (ΔQ29) | 625 | |||
| XV | 47.02 | 12, 357 | 12,358 | γ2-CN A, 0P | 1,473 | |
| 12,376 | 12,376 | γ2-CN B, 0P | 1,065 |
Major proteins within each peak are in bold. Proteins and isoforms previously described are on grey background.
*(GaN-Ga-SA2) x 3, or (GaN-Ga) + (GaN-Ga-SA3) x 2, or (GaN-Ga-SA)+(GaN-Ga-SA2)+(GaN-Ga-SA3).
**(GaN-Ga) x 3 + (GaN-Ga-SA2) x 2, or (GaN-Ga) + (GaN-Ga-SA) x 4, or (GaN-Ga) x 2 + (GaN-Ga-SA) x 2 + (GaN-Ga-SA2), or (GaN-Ga) x 3 + (GaN-Ga-SA) + (GaN-Ga-SA3).
***n/a—not applicable.
Relative proportion of each CN expressed in %, estimated from the mass signal intensity of each CN family relatively to the sum of mass signal intensities of all CN families in the three camel species.
| κ-CN | αs1-CN | αs2-CN | β-CN | |||||
|---|---|---|---|---|---|---|---|---|
| m | σ | m | σ | m | σ | m | σ | |
| 3,09 | 1,89 | 36,09 | 2,33 | 7,13 | 1,49 | 53,68 | 2,08 | |
| 3,63 | 2,13 | 37,39 | 3,89 | 5,79 | 0,98 | 53,19 | 3,46 | |
| 4,77 | 3,01 | 37,57 | 3,03 | 5,25 | 1,56 | 52,41 | 4,18 | |
m = mean.
σ = standard deviation.
Fig 5Amino acid sequence of mature camel αs2-CN with potential phosphorylation sites.
Seryl and Threonyl residues matching the S/T-X-A motif are in red and blue, respectively, and underlined. Threonyl residues matching the S/T-X-X-A motif are in green and underlined.